Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19295082 | 0.82 | DGAT1 (0.47) | DGAT1LPLLIPG | |
| SCHEMBL19794327 | 0.81 | DGAT1 (0.47) | DGAT1HIF1ALPLLIPG | |
| SCHEMBL19933760 | 0.81 | DGAT1 (0.47) | DGAT1HIF1ALPLLIPG | |
| SCHEMBL19794326 | 0.80 | DGAT1 (0.49) | DGAT1HIF1ALPLLIPG | |
| SCHEMBL21125417 | 0.75 | DGAT1 (0.41) | DGAT1LPLLIPG | |
| SCHEMBL23956047 | 0.74 | DGAT1 (0.42) | DGAT1LPLLIPG | |
| SCHEMBL19295084 | 0.73 | DGAT1 (0.47) | DGAT1LPLLIPG | |
| SCHEMBL21662364 | 0.73 | DGAT1 (0.43) | DGAT1LPLLIPG | |
| SCHEMBL21662278 | 0.73 | DGAT1 (0.41) | DGAT1LPLLIPG | |
| SCHEMBL23343403 | 0.73 | GRM5 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | AP2M1, MCU, AP3M1 | DGAT1 1147/4885HIF1A 4882/4885LPL 3633/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | DGAT1 1147/4885HIF1A 4882/4885LPL 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.